These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Regulation of monokine gene expression: prostaglandin E2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-associated bioactivity. Scales WE; Chensue SW; Otterness I; Kunkel SL J Leukoc Biol; 1989 May; 45(5):416-21. PubMed ID: 2651547 [TBL] [Abstract][Full Text] [Related]
10. Analysis of IL-1 and TNF-alpha gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization. MacNaul KL; Hutchinson NI; Parsons JN; Bayne EK; Tocci MJ J Immunol; 1990 Dec; 145(12):4154-66. PubMed ID: 2258613 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation. Meja KK; Barnes PJ; Giembycz MA Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541 [TBL] [Abstract][Full Text] [Related]
12. Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. Wertheim WA; Kunkel SL; Standiford TJ; Burdick MD; Becker FS; Wilke CA; Gilbert AR; Strieter RM J Immunol; 1993 Aug; 151(4):2166-75. PubMed ID: 8345201 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes. Seldon PM; Barnes PJ; Giembycz MA Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245 [TBL] [Abstract][Full Text] [Related]
15. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors. Gantner F; Kupferschmidt R; Schudt C; Wendel A; Hatzelmann A Br J Pharmacol; 1997 May; 121(2):221-31. PubMed ID: 9154331 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-4 as a potent down-regulator for human alveolar macrophages capable of producing tumour necrosis factor-alpha and interleukin-1. Sone S; Yanagawa H; Nishioka Y; Orino E; Bhaskaran G; Nii A; Mizuno K; Heike Y; Ogushi F; Ogura T Eur Respir J; 1992 Feb; 5(2):174-81. PubMed ID: 1559582 [TBL] [Abstract][Full Text] [Related]
17. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase. Seldon PM; Barnes PJ; Meja K; Giembycz MA Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903 [TBL] [Abstract][Full Text] [Related]
18. Regulation of tumor necrosis factor-alpha and IL-1 beta synthesis by thromboxane A2 in nonadherent human monocytes. Caughey GE; Pouliot M; Cleland LG; James MJ J Immunol; 1997 Jan; 158(1):351-8. PubMed ID: 8977210 [TBL] [Abstract][Full Text] [Related]
19. Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes. Hart PH; Whitty GA; Piccoli DS; Hamilton JA Immunology; 1989 Mar; 66(3):376-83. PubMed ID: 2495247 [TBL] [Abstract][Full Text] [Related]
20. Production of tumor necrosis factor-alpha by blood and lung mononuclear phagocytes from patients with human immunodeficiency virus-related lung disease. Millar AB; Miller RF; Foley NM; Meager A; Semple SJ; Rook GA Am J Respir Cell Mol Biol; 1991 Aug; 5(2):144-8. PubMed ID: 1892644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]